Reviewing Acadia Healthcare (ACHC) and Its Competitors

Acadia Healthcare (NASDAQ: ACHC) is one of 50 publicly-traded companies in the “Healthcare Facilities & Services” industry, but how does it contrast to its rivals? We will compare Acadia Healthcare to related businesses based on the strength of its profitability, risk, analyst recommendations, dividends, institutional ownership, valuation and earnings.

Insider and Institutional Ownership

74.7% of shares of all “Healthcare Facilities & Services” companies are held by institutional investors. 11.1% of Acadia Healthcare shares are held by company insiders. Comparatively, 12.4% of shares of all “Healthcare Facilities & Services” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Acadia Healthcare and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Acadia Healthcare 0.30% 8.69% 3.16%
Acadia Healthcare Competitors 9.07% 0.33% 0.50%

Risk and Volatility

Acadia Healthcare has a beta of 1.14, meaning that its stock price is 14% more volatile than the S&P 500. Comparatively, Acadia Healthcare’s rivals have a beta of 1.02, meaning that their average stock price is 2% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Acadia Healthcare and its rivals, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Acadia Healthcare 0 3 8 1 2.83
Acadia Healthcare Competitors 264 1567 1963 38 2.46

Acadia Healthcare presently has a consensus price target of $59.09, indicating a potential upside of 29.19%. As a group, “Healthcare Facilities & Services” companies have a potential downside of 8.67%. Given Acadia Healthcare’s stronger consensus rating and higher probable upside, equities analysts clearly believe Acadia Healthcare is more favorable than its rivals.

Valuation and Earnings

This table compares Acadia Healthcare and its rivals revenue, earnings per share (EPS) and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
Acadia Healthcare $2.83 billion $574.61 million 508.22
Acadia Healthcare Competitors $5.89 billion $843.94 million 34.49

Acadia Healthcare’s rivals have higher revenue and earnings than Acadia Healthcare. Acadia Healthcare is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Summary

Acadia Healthcare beats its rivals on 7 of the 13 factors compared.

About Acadia Healthcare

Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities. The Company is engaged in operating acute inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers and facilities providing outpatient behavioral healthcare services. As of December 31, 2016, the U.S. Facilities segment included 208 behavioral healthcare facilities with approximately 8,500 beds in 39 states and Puerto Rico, and the U.K. Facilities segment included 365 behavioral healthcare facilities with approximately 8,600 beds in the United Kingdom. As of December 31, 2016, the Company had operated 573 behavioral healthcare facilities with approximately 17,100 beds in 39 states, the United Kingdom and Puerto Rico.

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply